RxDoctor Payments Data

Kimberly Malka, MD

Vascular Surgery · Portland, MENPI 1770921462

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,612 of the $7,888 with a category attached, or 71.1%. 12 manufacturers reported payments, led by Lemaitre Vascular, Inc. at 28.3% of the total. Reporting peaked in 2019 at $2,905 and has fallen 84.8% since, to $442 in 2025.

$7,888in general payments, 2019–2025

Across 58 payments — averaging $136.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lemaitre Vascular, Inc.$2K
  • W. L. Gore & Associates, Inc.$1K
  • Medtronic$914
  • Cook Medical LLC$683
  • Endologix LLC$673
  • Silk Road Medical, Inc.$632
  • plus $1K from 6 others

What the payments were for

  • Travel & lodging$2,27629%
  • Food & beverage$5,61271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,888 in reported general payments places this provider in the 70th percentile of 30 vascular surgery providers in Maine.

See all vascular surgery providers in Maine

Medicare billing

Part B allowed, 2024
$44,527
Medicare patients
202
Services billed
388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol30$294

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Portland

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →